Is a pancreatic tumor the same as pancreatic cancer?

Written by Liu Liang
Oncology
Updated on September 03, 2024
00:00
00:00

Pancreatic tumors include benign and malignant tumors of the pancreas. Common benign pancreatic tumors include insulinomas, which can cause hypoglycemia due to excessive insulin secretion. Other benign tumors of the pancreas include adenomas, lipomas, and fibromas, which are relatively rare clinically. Malignant tumors of the pancreas are commonly referred to as pancreatic cancer, which has a high degree of malignancy. Early-stage pancreatic cancer patients are primarily treated with surgery.

Other Voices

doctor image
home-news-image
Written by Liu Liang
Oncology
1min 3sec home-news-image

What does pancreatic cancer ascites mean?

When pancreatic cancer causes ascites, particularly a large amount, we can collect the ascites to search for cancer cells. This generally indicates peritoneal metastasis, or metastasis above the liver which can also cause substantial ascites. In such cases, it typically signifies that the disease has progressed to a late stage, classified as stage IV. Patients in this category are unable to undergo surgery and their treatment primarily involves chemotherapy. If the patient's overall condition is good, chemotherapy can be chosen. If the patient's condition is relatively poor, targeted therapy or oral anti-angiogenesis medications may be selected to control the pancreatic cancer and manage the tumor. If the patient's condition is particularly poor, the approach involves placing a peritoneal drainage tube to remove the ascites and providing the best possible symptomatic supportive care.

doctor image
home-news-image
Written by Yan Chun
Oncology
1min 9sec home-news-image

Does pancreatic cancer cause bloody stools?

Patients with pancreatic cancer may exhibit clinical symptoms of bloody stools, and the possible causes are as follows: First, the lesion of pancreatic cancer invades organs and tissues such as the gastrointestinal tract, causing damage to the mucous membranes, which clinically results in bloody stools. Second, if the pancreatic cancer metastasizes to the liver, liver function is impaired. Some patients may develop hyperactive splenic function, leading to a decline in platelet counts. When platelet levels drop to a certain extent, spontaneous visceral bleeding can occur, which may also manifest as bloody stools clinically. Third, in the late stages of pancreatic cancer, the disease may cause metastasis to multiple organs, leading to the complication of disseminated intravascular coagulation. This results in impaired coagulation function, making gastrointestinal bleeding likely, which is also clinically manifested as bloody stools.

doctor image
home-news-image
Written by Shen Jiang Chao
Radiology
50sec home-news-image

Can pancreatic cancer be detected by a CT scan?

Pancreatic cancer can be detected by CT, which shows both direct and indirect signs. The direct signs of pancreatic cancer are manifested as pancreatic masses, which are mostly lobulated. On plain scans, the tumor appears isodense or slightly hypodense compared to the pancreatic parenchyma. When the tumor is large, it appears as a local protrusion, mostly located within the pancreas. In the early phase after enhancement, the tumor enhances less than the surrounding normal pancreatic tissue because pancreatic cancer is a hypovascular tumor. Indirect signs are mainly secondary changes caused by pancreatic cancer, mainly affecting the common bile duct and the main pancreatic duct, which can lead to pancreatic duct dilation, characterized by the typical double duct sign.

doctor image
home-news-image
Written by Liu Liang
Oncology
56sec home-news-image

How to screen for pancreatic cancer

Pancreatic cancer is a common malignant tumor of the digestive tract. Due to its high malignancy and rapid progression, it severely affects human health. So how should pancreatic cancer patients be screened? Generally, abdominal ultrasound examination is the primary screening method. Another method is the examination of tumor markers, mainly carcinoembryonic antigen (CEA) and CA19-9. CA19-9 is a tumor marker with relatively high specificity and sensitivity for the diagnosis of pancreatic cancer. Therefore, during physical examinations, we can draw blood to check these tumor markers. If there is a significant increase in CA19-9 or CEA, further examinations of the pancreas, such as ultrasound or CT of the pancreas, should be conducted to further investigate whether there is a tumor in the pancreas.

doctor image
home-news-image
Written by Sun Ming Yue
Medical Oncology
59sec home-news-image

Classification of the Malignancy of Pancreatic Cancer

Pancreatic cancer can also be described as a malignant tumor occurring in the pancreas, generally with a high malignancy level, resulting in a higher probability of patient death. To understand the classification of pancreatic cancer, it can be categorized based on the location of occurrence within the pancreas and the pathological type. Based on the location of occurrence, pancreatic cancer can generally be divided into cancers of the pancreatic head, body, tail, and entire pancreas. According to the pathological types of pancreatic cancer, it can be classified into ductal adenocarcinoma, and also some special types of ductal-origin cancers, which generally include pleomorphic carcinoma, mucinous carcinoma, adenosquamous carcinoma, mucinous cystadenocarcinoma, and signet ring cell carcinoma, among others.